Family Med Journals

Family Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nguyen MH et al. – No rtM204V/I or rtN236T mutations were observed in study. Less than 1% of patients had mutations that can be associated with primary resistance to existing anti–viral therapies for hepatitis B virus.

Related Articles

Hepatitis B does not increase risk for pancreatic cancer
EurekAlert, 11/02/09    Relevance Score: 70%

Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Clinical Gastroenterology and Hepatology, 10/09/09    Relevance Score: 70%

Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis
Rheumatology International, 11/13/09    Relevance Score: 69%

Entecavir for the long-term treatment of chronic hepatitis B
Expert Review of Anti-infective Therapy, 11/09/09    Relevance Score: 69%

Hepatitis B Virus Resistance to Nucleostide Analogues
Gastroenterology, 10/28/09    Relevance Score: 69%

Today in Gastroenterology...keeping you current

Herbal remedies are the main etiologic factor in melanosis coli, a case series study
Central European Journal of Medicine, 12/10/09

Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study
American Journal of Clinical Nutrition, 12/10/09

Irritable bowel syndrome - The role of complementary medicines in treatment
Australian Family Physician, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address